This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
fin-tech: Archive
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
OppFi's Adjusted EPS Guidance for 2025 Raised Again: Can it Deliver?
by Arghyadeep Bose
OPFI raises its 2025 EPS outlook after strong quarterly gains, improved credit trends and confidence in Model 6's predictive power.
artificial-intelligence business-services fin-tech
Prediction Markets a Key Driver in Reshaping Robinhood's Revenue Mix
by Swayta Shah
HOOD's prediction markets business surge is reshaping its revenue mix as event-contract trading becomes the firm's fastest-growing operation.
cryptocurrency fin-tech finance
Implied Volatility Surging for Navient Stock Options
by Zacks Equity Research
Investors need to pay close attention to NAVI stock based on the movements in the options market lately.
fin-tech finance
Twilio (TWLO) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Nexa Resources S.A. (NEXA)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
PayPal vs. Block: Which Fintech Stock is a Better Buy Right Now?
by Rohit Vasant Fatarpekar
PayPal's rising profitability and platform upgrades contrast with Block's rapid Cash App-driven growth in this fintech face-off.
fin-tech finance
FIS Expands Fintech Presence With New Tools on Microsoft Marketplace
by Zacks Equity Research
Fidelity National brings its AI-driven treasury and receivables tools to Microsoft Marketplace to fuel global adoption and cloud revenue momentum.
artificial-intelligence business-services fin-tech finance
Is Upstart Stock a Buy, Hold or Sell After a Steep 41% 3-Month Drop?
by Moumita C. Chattopadhyay
UPST's sharp three-month drop contrasts with a strong quarter as model shifts, funding gains and macro sensitivity shape a cautious hold outlook.
artificial-intelligence fin-tech finance
Can SE's Rapidly Expanding DFS Unit Sustain Its Revenue Strength?
by Zacks Equity Research
SE Limited's DFS unit posts 60% revenue growth as its loan book nears $8B, fueled by strong demand, rising adoption and broader product expansion.
fin-tech internet tech-stocks